{"id":"https://openalex.org/W7225628738","doi":"https://doi.org/10.14450/infarma.e202623","title":"NANOPARTICLE-BASED INTRANASAL DELIVERY SYSTEMS FOR BRAIN TARGETING IN DEPRESSION: MECHANISMS, THERAPEUTIC OUTCOMES, AND TRANSLATIONAL CHALLENGES","display_name":"NANOPARTICLE-BASED INTRANASAL DELIVERY SYSTEMS FOR BRAIN TARGETING IN DEPRESSION: MECHANISMS, THERAPEUTIC OUTCOMES, AND TRANSLATIONAL CHALLENGES","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225628738","doi":"https://doi.org/10.14450/infarma.e202623"},"language":"en","primary_location":{"id":"doi:10.14450/infarma.e202623","doi":"https://doi.org/10.14450/infarma.e202623","is_oa":true,"landing_page_url":"https://doi.org/10.14450/infarma.e202623","pdf_url":"https://revistas.cff.org.br/infarma/article/download/3470/2058","source":{"id":"https://openalex.org/S2739151380","display_name":"Infarma - Ci\u00eancias Farmac\u00eauticas","issn_l":"0104-0219","issn":["0104-0219","2318-9312"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","latindex","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310312435","host_organization_name":"Federal Council of Pharmacy","host_organization_lineage":["https://openalex.org/P4310312435"],"host_organization_lineage_names":["Federal Council of Pharmacy"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infarma - Ci\u00eancias Farmac\u00eauticas","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://revistas.cff.org.br/infarma/article/download/3470/2058","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161319640","display_name":"Chaitali Jaiswal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Chaitali Jaiswal","raw_affiliation_strings":["Dr. Rajendra Gode College Of Pharmacy, Malkapur"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Rajendra Gode College Of Pharmacy, Malkapur","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5161319640"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":null,"first_page":"e202623","last_page":"e202623"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9300000071525574},{"id":"https://openalex.org/keywords/intranasal-drug-delivery","display_name":"intranasal drug delivery","score":0.9549999833106995},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.6290000081062317},{"id":"https://openalex.org/keywords/nose-to-brain-drug-delivery","display_name":"nose-to-brain delivery","score":0.8289999961853027},{"id":"https://openalex.org/keywords/blood-brain-barrier-bypass","display_name":"blood-brain barrier bypass","score":0.8970000147819519},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.7229999899864197},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.4519999921321869},{"id":"https://openalex.org/keywords/mucociliary-clearance","display_name":"mucociliary clearance","score":0.7540000081062317},{"id":"https://openalex.org/keywords/chitosan","display_name":"chitosan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/polymeric-nanoparticles","display_name":"polymeric nanoparticles","score":0.7680000066757202},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.9390000104904175},{"id":"https://openalex.org/keywords/inorganic-nanoparticles","display_name":"inorganic nanoparticles","score":0.9890000224113464},{"id":"https://openalex.org/keywords/controlled-release","display_name":"controlled release","score":0.6809999942779541},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8289999961853027},{"id":"https://openalex.org/keywords/clinical-translation","display_name":"clinical translation","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.8773000240325928},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8141999840736389},{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.607200026512146},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4934000074863434},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46630001068115234},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4368000030517578},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4124000072479248},{"id":"https://openalex.org/C60903277","wikidata":"https://www.wikidata.org/wiki/Q2051926","display_name":"Paracellular transport","level":4,"score":0.37860000133514404},{"id":"https://openalex.org/C114682108","wikidata":"https://www.wikidata.org/wiki/Q1952044","display_name":"Mucociliary clearance","level":3,"score":0.3522000014781952},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3450999855995178},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.33959999680519104},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.3264000117778778},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.31610000133514404},{"id":"https://openalex.org/C2993043200","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical research","level":2,"score":0.29820001125335693},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.2913999855518341},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.290800005197525},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.26660001277923584},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2646999955177307},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.2646999955177307},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2540999948978424}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14450/infarma.e202623","doi":"https://doi.org/10.14450/infarma.e202623","is_oa":true,"landing_page_url":"https://doi.org/10.14450/infarma.e202623","pdf_url":"https://revistas.cff.org.br/infarma/article/download/3470/2058","source":{"id":"https://openalex.org/S2739151380","display_name":"Infarma - Ci\u00eancias Farmac\u00eauticas","issn_l":"0104-0219","issn":["0104-0219","2318-9312"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","latindex","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310312435","host_organization_name":"Federal Council of Pharmacy","host_organization_lineage":["https://openalex.org/P4310312435"],"host_organization_lineage_names":["Federal Council of Pharmacy"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infarma - Ci\u00eancias Farmac\u00eauticas","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.14450/infarma.e202623","doi":"https://doi.org/10.14450/infarma.e202623","is_oa":true,"landing_page_url":"https://doi.org/10.14450/infarma.e202623","pdf_url":"https://revistas.cff.org.br/infarma/article/download/3470/2058","source":{"id":"https://openalex.org/S2739151380","display_name":"Infarma - Ci\u00eancias Farmac\u00eauticas","issn_l":"0104-0219","issn":["0104-0219","2318-9312"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","latindex","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310312435","host_organization_name":"Federal Council of Pharmacy","host_organization_lineage":["https://openalex.org/P4310312435"],"host_organization_lineage_names":["Federal Council of Pharmacy"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infarma - Ci\u00eancias Farmac\u00eauticas","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225628738.pdf","grobid_xml":"https://content.openalex.org/works/W7225628738.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7115174613","https://openalex.org/W7154498117","https://openalex.org/W4411155856","https://openalex.org/W3116894714","https://openalex.org/W4311853299","https://openalex.org/W3036987863","https://openalex.org/W4320926250","https://openalex.org/W4297516107","https://openalex.org/W6968498318","https://openalex.org/W7166889277"],"abstract_inverted_index":{"Depression":[0],"is":[1,141],"still":[2,142],"one":[3],"of":[4,130,170],"the":[5,50,57,168],"most":[6],"severe":[7],"worldwide":[8],"health":[9],"disorders,":[10],"with":[11],"conventional":[12],"oral":[13],"antidepressant":[14],"medications":[15],"hampered":[16],"by":[17],"delayed":[18],"onset,":[19],"significant":[20,118,158],"first-pass":[21],"metabolism,":[22],"low":[23],"adherence,":[24],"and":[25,52,60,75,87,97,107,120,132,149,161],"limited":[26,143],"brain":[27,126],"penetration.":[28],"This":[29,152],"review":[30,153],"critically":[31],"assesses":[32],"nanoparticle-based":[33,173],"intranasal":[34,65,174],"delivery":[35],"options":[36],"designed":[37],"to":[38,145,165],"address":[39],"these":[40,137],"constraints.":[41,151],"Intranasal":[42],"injection":[43],"allows":[44],"for":[45],"direct":[46],"nose-to-brain":[47],"transport":[48],"via":[49],"olfactory":[51],"trigeminal":[53],"pathways,":[54],"which":[55,83],"bypasses":[56],"blood-brain":[58],"barrier":[59],"hepatic":[61],"metabolism.":[62],"However,":[63],"traditional":[64],"formulations":[66],"confront":[67],"problems":[68],"such":[69,123],"as":[70,124],"enzymatic":[71],"breakdown,":[72],"mucociliary":[73],"clearance,":[74],"a":[76],"short":[77],"nasal":[78],"residence":[79,105],"period.":[80],"Nanocarrier":[81],"systems,":[82],"include":[84],"polymeric,":[85],"lipid-based,":[86],"inorganic":[88],"nanoparticles,":[89],"improve":[90],"drug":[91],"solubility,":[92],"stability,":[93],"mucosal":[94],"retention,":[95],"penetration,":[96],"controlled":[98],"release.":[99],"Mucoadhesive":[100],"coatings":[101],"like":[102],"chitosan":[103],"enhance":[104],"duration":[106],"paracellular":[108],"transfer.":[109],"In":[110],"recent":[111],"preclinical":[112],"investigations,":[113],"antidepressant-loaded":[114],"nanoparticles":[115],"have":[116],"shown":[117],"pharmacokinetic":[119],"pharmacodynamic":[121],"advantages,":[122],"higher":[125],"bioavailability,":[127],"faster":[128],"start":[129],"action,":[131],"improved":[133],"behavioral":[134],"results.":[135],"Despite":[136],"advancements,":[138],"clinical":[139],"translation":[140],"due":[144],"safety,":[146],"regulatory,":[147],"manufacturing,":[148],"evaluation":[150],"summarizes":[154],"current":[155],"findings,":[156],"highlights":[157],"knowledge":[159],"gaps,":[160],"proposes":[162],"future":[163],"paths":[164],"aid":[166],"in":[167],"development":[169],"therapeutically":[171],"applicable":[172],"antidepressants.":[175]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}